Javascript must be enabled to continue!
Therapeutic effect of mifepristone combined with misoprostol in early missed miscarriage and prediction of incomplete abortion
View through CrossRef
Objective:
To compare the clinical efficacy of mifepristonemisoprostol medical management versus surgical curettage for first-trimester missed miscarriage, and to establish evidence-based sonographic cutoff values predictive of incomplete abortion requiring surgical intervention.
Methods:
We retrospectively analyzed a cohort of 702 women diagnosed with first-trimester missed miscarriage between January 2020 and May 2023. Demographic characteristics and ultrasound parameters were systematically recorded. Receiver operating characteristic (ROC) curve analysis was performed to establish optimal sonographic cutoff values for predicting incomplete abortion requiring surgical intervention.
Results:
146 patients received medical treatment (mifepristone and misoprostol) and 556 underwent surgical curettage. At the 1-month follow-up, the medical group showed significantly greater endometrial thickness and longer postoperative bleeding duration than the surgical group (P<0.05). The menstrual volume reduction rate (23.56%) was significantly lower in the medical group than in the surgical group. The incomplete abortion rate was higher in the medical group (17.12%, 25/146) than in the surgical group (2.88%, 16/556). Among the medical group, 14 patients (9.59%) required curettage due to incomplete abortion, while 11 cases resolved spontaneously after prolonged medication. ROC curve analysis identified two cut-off values indicating the need for surgical intervention: endometrial thickness >1.21 cm at 24 h post-medical abortion, and residual mass diameter >0.95 cm at 7 days post-medical abortion.
Conclusions:
Medical management of first-trimester missed miscarriage using mifepristone-misoprostol demonstrates comparable efficacy to surgical curettage. An endometrial thickness >1.21 cm at 24 h or residual tissue diameter >0.95 cm at 7 days post-medical abortion should prompt consideration of incomplete abortion.
Ovid Technologies (Wolters Kluwer Health)
Title: Therapeutic effect of mifepristone combined with misoprostol in early missed miscarriage and prediction of incomplete abortion
Description:
Objective:
To compare the clinical efficacy of mifepristonemisoprostol medical management versus surgical curettage for first-trimester missed miscarriage, and to establish evidence-based sonographic cutoff values predictive of incomplete abortion requiring surgical intervention.
Methods:
We retrospectively analyzed a cohort of 702 women diagnosed with first-trimester missed miscarriage between January 2020 and May 2023.
Demographic characteristics and ultrasound parameters were systematically recorded.
Receiver operating characteristic (ROC) curve analysis was performed to establish optimal sonographic cutoff values for predicting incomplete abortion requiring surgical intervention.
Results:
146 patients received medical treatment (mifepristone and misoprostol) and 556 underwent surgical curettage.
At the 1-month follow-up, the medical group showed significantly greater endometrial thickness and longer postoperative bleeding duration than the surgical group (P<0.
05).
The menstrual volume reduction rate (23.
56%) was significantly lower in the medical group than in the surgical group.
The incomplete abortion rate was higher in the medical group (17.
12%, 25/146) than in the surgical group (2.
88%, 16/556).
Among the medical group, 14 patients (9.
59%) required curettage due to incomplete abortion, while 11 cases resolved spontaneously after prolonged medication.
ROC curve analysis identified two cut-off values indicating the need for surgical intervention: endometrial thickness >1.
21 cm at 24 h post-medical abortion, and residual mass diameter >0.
95 cm at 7 days post-medical abortion.
Conclusions:
Medical management of first-trimester missed miscarriage using mifepristone-misoprostol demonstrates comparable efficacy to surgical curettage.
An endometrial thickness >1.
21 cm at 24 h or residual tissue diameter >0.
95 cm at 7 days post-medical abortion should prompt consideration of incomplete abortion.
Related Results
Comparison of Mifepristone plus Misoprostol with Misoprostol Alone for First Trimester Medical Abortion: A Systematic Review & Meta -Analysis Protocol
Comparison of Mifepristone plus Misoprostol with Misoprostol Alone for First Trimester Medical Abortion: A Systematic Review & Meta -Analysis Protocol
Abstract
Background Original clinical trials have demonstrated that the combined mifepristone plus misoprostol has a marked effectiveness on first trimester abortion practi...
Obat Aborsi Bandung | WA : 0858 6506 9949 | Obat Penggugur Kandungan Bandung | Obat Telat Bulan Bandung | Obat Cytotec Bandung | Obat Pelancar Haid Bandung
Obat Aborsi Bandung | WA : 0858 6506 9949 | Obat Penggugur Kandungan Bandung | Obat Telat Bulan Bandung | Obat Cytotec Bandung | Obat Pelancar Haid Bandung
Jual Obat Aborsi Bandung | Obat Penggugur kandungan Bandung | Pil Aborsi Janin Bandung | Obat Pil Penggugur Kandungan Bandung | Alamat Klinik Jual Obat Aborsi Bandung | Apotik Jual...
Global Epidemiology of Induced Abortion
Global Epidemiology of Induced Abortion
Induced abortion is a common reproductive experience, with more than 73 million abortions occurring each year globally. Worldwide, the annual abortion incidence decreased in the 19...
Efficacy of oral versus vaginal misoprostol in the management of first trimester incomplete miscarriage.
Efficacy of oral versus vaginal misoprostol in the management of first trimester incomplete miscarriage.
Objective: To compare the efficacy of oral versus vaginal misoprostol in first trimester incomplete miscarriage. Study Design: Cross-sectional study. Setting: Gynae B Unit of Lady ...
Physicians' abortion attitudes and intentions regarding future practice
Physicians' abortion attitudes and intentions regarding future practice
Since abortion became legal in the U.S. in 1973, the number of abortions performed annually has been relatively stable, while the number of abortion providers has drastically decre...
Re Application by the Northern Ireland Human Rights Commission for Judicial Review (Northern Ireland); Reference by Court of Appeal in Northern Ireland Pursuant to Paragraph 33 of Schedule 10 to the Northern Ireland Act 1998 (Abortion) (Northern Ireland)
Re Application by the Northern Ireland Human Rights Commission for Judicial Review (Northern Ireland); Reference by Court of Appeal in Northern Ireland Pursuant to Paragraph 33 of Schedule 10 to the Northern Ireland Act 1998 (Abortion) (Northern Ireland)
531Human rights — Rights of women in Northern Ireland — Pregnant women and girls — Autonomy and bodily integrity — Right to respect for private and family life — Rights of persons ...
P-383 Development and validation of a visualized prediction model for early miscarriage risk in patients undergoing IVF/ICSI procedures: a real-world multi-center study
P-383 Development and validation of a visualized prediction model for early miscarriage risk in patients undergoing IVF/ICSI procedures: a real-world multi-center study
Abstract
Study question
What are the key predictors of early miscarriage in patients undergoing IVF/ICSI treatment?
...
Second and Third Medical Termination of Pregnancy with Misoprostol without Mifepristone
Second and Third Medical Termination of Pregnancy with Misoprostol without Mifepristone
<i>Background:</i> Advances in prenatal diagnosis make it possible to detect many fetal pathologies for which a termination of pregnancy (TOP) is possible in France. In...

